Education
About Us
Working with TipRanks
Follow Us
OncoSil Medical Ltd (AU:OSL)
ASX:OSL
OSL Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$0.90 - AU$6.00
Previous CloseN/A
Volume350.23K
Average Volume (3M)24.58K
Market Cap
AU$32.10M
Enterprise ValueAU$9.21M
Total Cash (Recent Filing)AU$5.11M
Total Debt (Recent Filing)AU$69.92K
Price to Earnings (P/E)―
Beta0.47
Next Earnings
Mar 04, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.71
Shares Outstanding18,827,215
10 Day Avg. Volume19,845
30 Day Avg. Volume24,576
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)4.23
Price to Sales (P/S)11.20
P/FCF Ratio-1.09
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$1.50Price Target Upside-11.76% Downside
Rating ConsensusHold
Number of Analyst Covering0
OncoSil Medical Ltd News
OSL FAQ
What was OncoSil Medical Ltd’s price range in the past 12 months?
OncoSil Medical Ltd lowest share price was AU$0.90 and its highest was AU$6.00 in the past 12 months.
What is OncoSil Medical Ltd’s market cap?
OncoSil Medical Ltd’s market cap is AU$32.10M.
When is OncoSil Medical Ltd’s upcoming earnings report date?
OncoSil Medical Ltd’s upcoming earnings report date is Mar 04, 2026 which is in 147 days.
How were OncoSil Medical Ltd’s earnings last quarter?
OncoSil Medical Ltd released its earnings results on Aug 28, 2025. The company reported -AU$0.707 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.707.
Is OncoSil Medical Ltd overvalued?
According to Wall Street analysts OncoSil Medical Ltd’s price is currently Overvalued.
Does OncoSil Medical Ltd pay dividends?
OncoSil Medical Ltd does not currently pay dividends.
What is OncoSil Medical Ltd’s EPS estimate?
OncoSil Medical Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does OncoSil Medical Ltd have?
OncoSil Medical Ltd has 18,827,215 shares outstanding.
What happened to OncoSil Medical Ltd’s price movement after its last earnings report?
OncoSil Medical Ltd reported an EPS of -AU$0.707 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 2.679%.
Which hedge fund is a major shareholder of OncoSil Medical Ltd?
Currently, no hedge funds are holding shares in AU:OSL
OncoSil Medical Ltd Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
AU$1.50 (-11.76% Downside)
AU$1.50 (-11.76% Downside)
Blogger Sentiment
Bullish
AU:OSL Sentiment 100%
Sector Average 72%
Sector Average 72%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
―
20 days / 200 days
Momentum
-69.55%
12-Months-Change
Fundamentals
Return on Equity
-385.20%
Trailing 12-Months
Asset Growth
6.40%
Trailing 12-Months
Company Description
OncoSil Medical Ltd
OncoSil Medical Ltd (OSL) is an Australian medical device company specializing in the development and commercialization of innovative treatments for cancer patients. The company's core product, OncoSil™, is a brachytherapy device designed to deliver localized radiation therapy directly to pancreatic and liver tumors. OncoSil Medical Ltd operates within the biotechnology and medical device sectors, focusing on enhancing the quality of life and treatment outcomes for patients with difficult-to-treat cancers.
Technical Analysis
Cyclopharm Limited
―
Micro-X Ltd.
―
EMvision Medical Devices Ltd.
―
Control Bionics Ltd.
―
4DMedical Ltd
―